Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Archive
Search for this keyword
Advanced search
Close
More
Main menu
Archive
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 74, Issue 2
Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
This article has a correction. Please see:
Correction: Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study - July 01, 2016
PDF
PDF +
Supplementary
Material
Clinical and epidemiological research
Extended report
Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
Online download statistics by month:
Online download statistics by month: November 2013 to January 2025
Abstract
Full
Pdf
Nov 2013
600
63
145
Dec 2013
900
338
362
Jan 2014
218
79
103
Feb 2014
62
67
71
Mar 2014
66
62
84
Apr 2014
32
65
48
May 2014
44
64
64
Jun 2014
39
69
69
Jul 2014
35
65
70
Aug 2014
26
39
51
Sep 2014
26
51
54
Oct 2014
29
52
67
Nov 2014
22
50
50
Dec 2014
21
50
42
Jan 2015
1572
125
338
Feb 2015
602
62
209
Mar 2015
285
97
189
Apr 2015
168
59
148
May 2015
110
54
66
Jun 2015
106
52
52
Jul 2015
83
51
70
Aug 2015
63
37
51
Sep 2015
95
32
43
Oct 2015
64
22
20
Nov 2015
54
31
54
Dec 2015
56
31
29
Jan 2016
96
53
61
Feb 2016
54
37
47
Mar 2016
92
42
53
Apr 2016
80
35
55
May 2016
52
33
53
Jun 2016
46
29
40
Jul 2016
55
32
45
Aug 2016
57
42
45
Sep 2016
60
26
40
Oct 2016
51
46
49
Nov 2016
49
31
37
Dec 2016
38
34
30
Jan 2017
57
32
40
Feb 2017
14
22
23
Mar 2017
15
51
30
Apr 2017
6
62
36
May 2017
8
53
24
Jun 2017
23
57
29
Jul 2017
62
53
35
Aug 2017
65
59
59
Sep 2017
78
68
21
Oct 2017
71
55
22
Nov 2017
94
69
24
Dec 2017
47
39
24
Jan 2018
93
84
45
Feb 2018
53
43
15
Mar 2018
55
47
16
Apr 2018
85
43
22
May 2018
60
40
11
Jun 2018
72
54
16
Jul 2018
74
60
22
Aug 2018
76
62
40
Sep 2018
55
45
19
Oct 2018
61
39
29
Nov 2018
69
43
47
Dec 2018
57
51
22
Jan 2019
62
49
30
Feb 2019
60
53
21
Mar 2019
91
59
24
Apr 2019
72
60
29
May 2019
57
48
26
Jun 2019
58
50
10
Jul 2019
69
59
20
Aug 2019
64
58
25
Sep 2019
58
53
23
Oct 2019
96
77
29
Nov 2019
79
55
32
Dec 2019
79
67
25
Jan 2020
105
84
43
Feb 2020
108
101
18
Mar 2020
95
87
20
Apr 2020
209
203
16
May 2020
107
90
28
Jun 2020
69
45
24
Jul 2020
83
77
22
Aug 2020
90
75
23
Sep 2020
88
74
23
Oct 2020
98
89
22
Nov 2020
84
76
30
Dec 2020
112
90
18
Jan 2021
98
87
27
Feb 2021
80
64
26
Mar 2021
111
95
51
Apr 2021
77
71
27
May 2021
74
73
15
Jun 2021
66
65
16
Jul 2021
68
68
21
Aug 2021
75
75
16
Sep 2021
99
98
19
Oct 2021
109
103
38
Nov 2021
99
85
40
Dec 2021
86
76
17
Jan 2022
130
114
18
Feb 2022
84
82
27
Mar 2022
118
110
19
Apr 2022
144
119
26
May 2022
141
123
36
Jun 2022
111
101
28
Jul 2022
114
104
19
Aug 2022
179
176
20
Sep 2022
127
121
15
Oct 2022
161
131
23
Nov 2022
160
151
17
Dec 2022
117
107
17
Jan 2023
159
146
32
Feb 2023
169
161
25
Mar 2023
160
154
31
Apr 2023
79
73
16
May 2023
99
91
19
Jun 2023
95
93
11
Jul 2023
105
102
19
Aug 2023
94
84
20
Sep 2023
104
102
12
Oct 2023
188
184
15
Nov 2023
262
246
12
Dec 2023
165
153
26
Jan 2024
61
61
32
Feb 2024
102
100
18
Mar 2024
101
97
74
Apr 2024
146
130
20
May 2024
133
122
24
Jun 2024
76
65
21
Jul 2024
117
110
15
Aug 2024
134
113
148
Sep 2024
87
88
10
Oct 2024
124
111
29
Nov 2024
115
113
23
Dec 2024
176
165
23
Jan 2025
155
149
25
Total
15385
10629
5634
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?